An Evaluation of Fructosamine Estimation in Screening for Gestational Diabetes Mellitus

P. F. Hughes, M. Agarwal, P. Newman, J. Morrison

Research output: Contribution to journalArticlepeer-review

32 Citations (Scopus)


Although persuasive arguments against routine screening for gestational diabetes mellitus (GDM) have been made, it is widely but not universally performed as a part of antenatal care. There is no international agreement on methods or criteria used for screening (or for diagnosis), and administered glucose‐load methods have significant practical difficulties in a busy antenatal clinic setting. However, recent evidence supports the concept of an increased level of importance being given to a diagnosis of GDM, with interest in the fetal and neonatal origins of adult disease being added to the short‐term obstetric and fetal concern during pregnancy. A second generation fructosamine test, corrected for total protein, has been evaluated as a practical alternative to glucose screening for GDM in a busy, multi‐ethnic antenatal clinic. This achieved a 79.4 % sensitivity and a 77.3 % specificity for a diagnosis of GDM confirmed by a glucose tolerance test using Carpenter's modified criteria. In view of the organizational simplicity of this sample/test requirement, a wider evaluation is suggested together with a re‐evaluation of clinical outcome criteria rather than blood glucose levels alone. 1995 Diabetes UK

Original languageEnglish
Pages (from-to)708-712
Number of pages5
JournalDiabetic Medicine
Issue number8
Publication statusPublished - Aug 1995
Externally publishedYes


  • Fructosamine
  • Gestational diabetes
  • Screening

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'An Evaluation of Fructosamine Estimation in Screening for Gestational Diabetes Mellitus'. Together they form a unique fingerprint.

Cite this